BE813251A - Procede pour prolonger l'effet de composes pharmaceutiques - Google Patents

Procede pour prolonger l'effet de composes pharmaceutiques

Info

Publication number
BE813251A
BE813251A BE142809A BE142809A BE813251A BE 813251 A BE813251 A BE 813251A BE 142809 A BE142809 A BE 142809A BE 142809 A BE142809 A BE 142809A BE 813251 A BE813251 A BE 813251A
Authority
BE
Belgium
Prior art keywords
prolonging
effect
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
BE142809A
Other languages
English (en)
Inventor
L Molteni
E Antonini
A Trebbi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE813251A publication Critical patent/BE813251A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BE142809A 1973-04-04 1974-04-03 Procede pour prolonger l'effet de composes pharmaceutiques BE813251A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22595/73A IT1053718B (it) 1973-04-04 1973-04-04 Metodo per prolungare l azione di farmaci attraverso la formazione di composti mcromolecolari

Publications (1)

Publication Number Publication Date
BE813251A true BE813251A (fr) 1974-07-31

Family

ID=11198242

Family Applications (1)

Application Number Title Priority Date Filing Date
BE142809A BE813251A (fr) 1973-04-04 1974-04-03 Procede pour prolonger l'effet de composes pharmaceutiques

Country Status (5)

Country Link
JP (1) JPS5035316A (fr)
BE (1) BE813251A (fr)
DE (1) DE2413512A1 (fr)
FR (1) FR2224164A1 (fr)
IT (1) IT1053718B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152820A (ja) * 1982-03-04 1983-09-10 Kyosei Seiyaku Kk 癌治療用組成物
EP0224987B1 (fr) * 1985-11-29 1992-04-15 Biomatrix, Inc. Systèmes à base de l'hyaluronanne, de ses dérivés et de ses sels pour la libération de médicaments et leur procédé de fabrication
ATE166361T1 (de) * 1991-02-21 1998-06-15 Drug Delivery System Inst Ltd Carboxymethylmannoglukan und derivate davon
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
ES2670969T3 (es) 2012-11-13 2018-06-04 Adocia Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue

Also Published As

Publication number Publication date
JPS5035316A (fr) 1975-04-04
FR2224164A1 (en) 1974-10-31
IT1053718B (it) 1981-10-10
DE2413512A1 (de) 1974-10-24

Similar Documents

Publication Publication Date Title
BE821983A (fr) Procede pour la preparation d'hydroxycholesterines
RO63965A (fr) Procede pour la preparation d'acides phenylpropioniques
RO63761A (fr) Procede pour la preparation des derives 0-substitues-d'acide-7-beta-amino-3-cephem 3-ole-4-carboxylique
BE822990A (fr) Procede pour la preparation d'hexamethyltetraline
RO65957A (fr) Procede pour la preparation des piperazinyle-quinazolines
RO66825A (fr) Procede pour la preparation de l'acetate de trans-7-cis-9-dodecadien-1-yl
RO63539A (fr) Procede pour la preparation des piperazinylquinoxalines
BE812104A (fr) Procede pour la preparation d'aldehydes
BE813251A (fr) Procede pour prolonger l'effet de composes pharmaceutiques
RO63655A (fr) Procede pour la preparation des derives d'isoquinoline
RO63749A (fr) Procede pour la preparation des 5-pyrazolones-1-substituees
RO63724A (fr) Procede pour la preparation des derives d'oxadiazolone
FR2303543A1 (fr) Nouveau procede pour la preparation de l'amoxycilline
BE817761A (fr) Procede de preparation d'o-benzyltoluenes
RO63730A (fr) Procede pour la preparation des derives d'indoline
RO63035A (fr) Procede pour la preparation des 2-phenylaminoimidazolines-(2)-substitues
RO68378A (fr) Procede pour la preparation des n-benzhidryle-n'-p-hydroxybenzyle-piperazines
BE820662A (fr) Procede photochimique pour la preparation de composes d'addition des hydrocarbures
RO63792A (fr) Procede pour la preparation d'ergolines-0-6-methyle-2-8-substituees
RO68008A (fr) Procede pour la preparation des poles-n-alkyle-iminoalanes
RO64595A (fr) Procede pour la preparation des composes 3-halogene-cephalosporines e-cephalo sporines
RO63505A (fr) Procede pour la preparation des derives d'indole
RO62902A (fr) Procede pour la preparation des derives d'oxindole
BE763130A (fr) Procede continu de preparation de composes d'aluminium-alcoyle
BE822618A (fr) Nouveau procede de preparation de l'antibiotique